The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Global Cancer Statistics, 2002
Open accessAbstract
Estimates of the worldwide incidence, mortality and prevalence of 26 cancers in the year 2002 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. The results are presented here in summary form, including the geographic variation between 20 large "areas" of the world. Overall, there were 10.9 million new cases, 6.7 million deaths, and 24.6 million persons alive with cancer (within three years of diagnosis). The most commonly diagnosed cancers are lung (1.35 million), breast (1.15 million), and colorectal (1 million); the most common causes of cancer death are lung cancer (1.18 million deaths), stomach cancer (700,000 deaths), and liver cancer (598,000 deaths). The most prevalent cancer in the world is breast cancer (4.4 million survivors up to 5 years following diagnosis). There are striking variations in the risk of different cancers by geographic area. Most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationCancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Molecular biology of human papillomavirus infection and cervical cancer
Doorbar, J. (2006) · Clinical Science · doi:10.1042/cs20050369 · Cited by 1,072
Arbyn, M., Verdoodt, F., Snijders, P. J. F., Verhoef, V. M. J., Suonio, E., Dillner, L., Minozzi, S., Bellisario, C., Banzi, R., Zhao, F.-H., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70570-9 · Cited by 674
Recent Trends in Lung Cancer Mortality in the United States
Jemal, A., Chu, K. C., & Tarone, R. E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.277 · Cited by 167
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Cited by
Items 101–164 of 164
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
Bakkum-Gamez, J. N., Wentzensen, N., Maurer, M. J., Hawthorne, K. M., Voss, J. S., Kroneman, T. N., Famuyide, A. O., Clayton, A. C., Halling, K. C., Kerr, S. E., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.552 · Cited by 107
Prognostic role of CIP2A expression in serous ovarian cancer
Böckelman, C., Lassus, H., Hemmes, A., Leminen, A., Westermarck, J., Haglund, C., Bützow, R., & Ristimäki, A. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.346 · Cited by 100
“Incidence rates have increased slowly in developed countries, with an incidence rate of 9 per 100 000 (Parkin et al, 2005).”
BackgroundSUZUKI, S., YOKOBORI, T., TANAKA, N., SAKAI, M., SANO, A., INOSE, T., SOHDA, M., NAKAJIMA, M., MIYAZAKI, T., KATO, H., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1831 · Cited by 100
Smout, M. J., Sotillo, J., Laha, T., Papatpremsiri, A., Rinaldi, G., Pimenta, R. N., Chan, L. Y., Johnson, M. S., Turnbull, L., Whitchurch, C. B., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005209 · Cited by 94
Ren, J. S., Freedman, N. D., Kamangar, F., Dawsey, S. M., Hollenbeck, A. R., Schatzkin, A., & Abnet, C. C. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.025 · Cited by 99
Lahner, E., Esposito, G., Pilozzi, E., Purchiaroni, F., Corleto, V. D., Di Giulio, E., & Annibale, B. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1010570 · Cited by 97
Genome Analysis of Latin American Cervical Cancer: Frequent Activation of the PIK3CA Pathway
Lou, H., Villagran, G., Boland, J. F., Im, K. M., Polo, S., Zhou, W., Odey, U., Juárez-Torres, E., Medina-Martínez, I., Roman-Basaure, E., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1837 · Cited by 88
Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer
Saito, H., Kuroda, H., Matsunaga, T., Osaki, T., & Ikeguchi, M. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23281 · Cited by 94
Lee, P., Bazan, J. G., Lavori, P. W., Weerasuriya, D. K., Quon, A., Le, Q.-T., Wakelee, H. A., Graves, E. E., & Loo, B. W. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.05.001 · Cited by 92
He, J., Zhou, M., Chen, X., Yue, D., Yang, L., Qin, G., Zhang, Z., Gao, Q., Wang, D., Zhang, C., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0378-z · Cited by 85
Coffee Consumption and Risk of Colorectal Cancer: A Meta-Analysis of Case-Control Studies
Galeone, C., Turati, F., La Vecchia, C., & Tavani, A. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9623-5 · Cited by 86
Cai, H., Xu, Z., Xu, T., Yu, B., & Zou, Q. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2582 · Cited by 80
Prospective weight change and colon cancer risk in male US health professionals
Thygesen, L. C., Grønbæk, M., Johansen, C., Fuchs, C. S., Willett, W. C., & Giovannucci, E. (2008) · International Journal of Cancer · doi:10.1002/ijc.23612 · Cited by 78
Pinato, D. J., Cortellini, A., Sukumaran, A., Cole, T., Pai, M., Habib, N., Spalding, D., Sodergren, M. H., Martinez, M., Dhillon, T., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08033-x · Cited by 79
eC3-A Modern Telecommunications Matrix for Cervical Cancer Prevention in Zambia
Parham, G. P., Mwanahamuntu, M. H., Pfaendler, K. S., Sahasrabuddhe, V. V., Myung, D., Mkumba, G., Kapambwe, S., Mwanza, B., Chibwesha, C., Hicks, M. L., et al. (2010) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e3181cd6d5e · Cited by 79
Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606005 · Cited by 78
Lutterbuese, R., Raum, T., Kischel, R., Lutterbuese, P., Schlereth, B., Schaller, E., Mangold, S., Rau, D., Meier, P., Kiener, P. A., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31819b7c70 · Cited by 77
Li, P., Chen, X., Su, L., Li, C., Zhi, Q., Yu, B., Sheng, H., Wang, J., Feng, R., Cai, Q., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066782 · Cited by 75
Xiao, F., zhang, W., Chen, L., Chen, F., Xie, H., Xing, C., Yu, X., Ding, S., Chen, K., Guo, H., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-195 · Cited by 71
Zheng, J.-S., Yang, J., Fu, Y.-Q., Huang, T., Huang, Y.-J., & Li, D. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.741762 · Cited by 70
Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1
LI, G.-C., ZHANG, H.-W., ZHAO, Q.-C., SUN, L., YANG, J.-J., HONG, L., FENG, F., & CAI, L. (2016) · Oncology Letters · doi:10.3892/ol.2015.3997 · Cited by 72
“Hepatocellular carcinoma (HCC) is the third leading cause of cancer-associated mortality worldwide (1,2).”
Hevir, N., Šinkovec, J., & Rižner, T. L. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.09.011 · Cited by 69
Farkas, S. A., Vymetalkova, V., Vodickova, L., Vodicka, P., & Nilsson, T. K. (2014) · Epigenomics · doi:10.2217/epi.14.7 · Cited by 67
Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer
Coe, B. P., Lockwood, W. W., Girard, L., Chari, R., MacAulay, C., Lam, S., Gazdar, A. F., Minna, J. D., & Lam, W. L. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603167 · Cited by 67
Use of Underarm Cosmetic Products in Relation to Risk of Breast Cancer: A Case-Control Study
Linhart, C., Talasz, H., Morandi, E. M., Exley, C., Lindner, H. H., Taucher, S., Egle, D., Hubalek, M., Concin, N., & Ulmer, H. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.06.005 · Cited by 66
Duong, C., Greenawalt, D. M., Kowalczyk, A., Ciavarella, M. L., Raskutti, G., Murray, W. K., Phillips, W. A., & Thomas, R. J. S. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9550-1 · Cited by 64
Hepatitis B control by 2012 in the WHO Western Pacific Region:
Rani, M. (2009) · Bulletin of the World Health Organization · doi:10.2471/blt.08.059220 · Cited by 61
Lung cancer and occupation: a New Zealand cancer registry-based case-control study
Corbin, M., McLean, D., Mannetje, A. '., Dryson, E., Walls, C., McKenzie, F., Maule, M., Cheng, S., Cunningham, C., Kromhout, H., et al. (2011) · American Journal of Industrial Medicine · doi:10.1002/ajim.20906 · Cited by 60
Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status
Zhang, C., Ho, S. C., Lin, F., Cheng, S., Fu, J., & Chen, Y. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01376.x · Cited by 59
Ellis, M. A., Sterba, K. R., Brennan, E. A., Maurer, S., Hill, E. G., Day, T. A., & Graboyes, E. M. (2019) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599819829018 · Cited by 56
Hussein, K. H., Park, K. M., Ghim, J. H., Yang, S. R., & Woo, H. M. (2016) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33384 · Cited by 56
Toxicometabolomics of Urinary Biomarkers for Human Gastric Cancer in a Mouse Model
Kim, K.-B., Yang, J.-Y., Kwack, S. J., Park, K. L., Kim, H. S., Ryu, D. H., Kim, Y.-J., Hwang, G.-S., & Lee, B. M. (2010) · Journal of Toxicology and Environmental Health, Part A · doi:10.1080/15287394.2010.511545 · Cited by 55
Xiang, Z.-L., Zeng, Z.-C., Fan, J., Tang, Z.-Y., He, J., Zeng, H.-Y., & Chang, J. Y. (2012) · Molecular Biology Reports · doi:10.1007/s11033-011-0949-1 · Cited by 52
Wright, K. O., Aiyedehin, O., Akinyinka, M. R., & Ilozumba, O. (2014) · ISRN Preventive Medicine · doi:10.1155/2014/950534 · Cited by 51
Kosus, N., Kosus, A., Duran, M., Simavli, S., & Turhan, N. (2010) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2010.24 · Cited by 49
Parkes‐Ratanshi, R., Achan, B., Kwizera, R., Kambugu, A., Meya, D., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12387 · Cited by 49
Effect of soybean on breast cancer according to receptor status: a case-control study in Japan
Suzuki, T., Matsuo, K., Tsunoda, N., Hirose, K., Hiraki, A., Kawase, T., Yamashita, T., Iwata, H., Tanaka, H., & Tajima, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.23644 · Cited by 47
Goldfarb, C. N., Karri, K., Pyatkov, M., & Waxman, D. J. (2022) · Endocrinology · doi:10.1210/endocr/bqac059 · Cited by 46
Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis
Anupam, K. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i37.6041 · Cited by 45
Gadoxetate acid-enhanced MR imaging for HCC: A review for clinicians
Chanyaputhipong, J., Low, S.-C. A., & Chow, P. K. H. (2011) · International Journal of Hepatology · doi:10.4061/2011/489342 · Cited by 41
Li, L., Feng, R., Xu, Q., Zhang, F., Liu, T., Cao, J., & Fei, S. (2017) · Oncotarget · doi:10.18632/oncotarget.20894 · Cited by 41
Yip, C. H., & Anderson, B. O. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.8.1095 · Cited by 36
Coffee Consumption and Risk of Gastric and Pancreatic Cancer—A Prospective Cohort Study
Bidel, S., Hu, G., Jousilahti, P., Pukkala, E., Hakulinen, T., & Tuomilehto, J. (2013) · International Journal of Cancer · doi:10.1002/ijc.27773 · Cited by 39
. FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients.
Park, L. S., Tate, J. P., Justice, A. C., Lo Re, V., Lim, J. K., Bräu, N., Brown, S. T., Butt, A. A., Gibert, C., Goetz, M. B., et al. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0582 · Cited by 38
Pollard, A., Burchell, J. L., Castle, D., Neilson, K., Ftanou, M., Corry, J., Rischin, D., Kissane, D. W., Krishnasamy, M., Carlson, L. E., et al. (2017) · European Journal of Cancer Care · doi:10.1111/ecc.12474 · Cited by 36
Inflammatory Events During Murine Squamous Cell Carcinoma Development
Gasparoto, T. H., de Oliveira, C. E., de Freitas, L. T., Pinheiro, C. R., Ramos, R. N., da Silva, A. L., Garlet, G. P., da Silva, J. S., & Campanelli, A. P. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-46 · Cited by 35
Gao, R., Wu, X., Huang, Z., Wang, B., Li, F., Xu, H., & Ran, L. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s182405 · Cited by 35
Lin, C., Chen, S., Simard, S., Chang, J. T., & Lai, Y. (2018) · Psycho-Oncology · doi:10.1002/pon.4697 · Cited by 33
Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography
Ahn, S. J., Choi, S. J., & Kim, H. S. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-016-9876-7 · Cited by 32
Sahasrabuddhe, V. V., Bhosale, R. A., Joshi, S. N., Kavatkar, A. N., Nagwanshi, C. A., Kelkar, R. S., Jenkins, C. A., Shepherd, B. E., Sahay, S., Risbud, A. R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008634 · Cited by 33
Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model
Hatting, M., Spannbauer, M., Peng, J., Al Masaoudi, M., Sellge, G., Nevzorova, Y. A., Gassler, N., Liedtke, C., Cubero, F. J., & Trautwein, C. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.590 · Cited by 30
Cervical Cancer Screening Among Young Adult Women in the United States
Roland, K. B., Benard, V. B., Soman, A., Breen, N., Kepka, D., & Saraiya, M. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1266 · Cited by 30
CHEN, Q., CHENG, P., YIN, T., HE, H., YANG, L., WEI, Y., & CHEN, X. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1015 · Cited by 27
SHEN, W., ZOU, X., CHEN, M., SHEN, Y., HUANG, S., GUO, H., ZHANG, L., & LIU, P. (2013) · Oncology Reports · doi:10.3892/or.2013.2524 · Cited by 26
Su, Y., Cheng, R., Zhang, J., Qian, J., Diao, C., Ran, J., Zhang, H., & Li, L. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.10.031 · Cited by 25
Rabben, H.-L., Andersen, G. T., Ianevski, A., Olsen, M. K., Kainov, D., Grønbech, J. E., Wang, T. C., Chen, D., & Zhao, C.-M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.625991 · Cited by 24
Vivar, C. G. (2012) · Atención Primaria · doi:10.1016/j.aprim.2011.07.011 · Cited by 24
Khan, S., Khan, N. A., Rehman, A. U., Khan, I., Samo, K. A., & Memon, A. S. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.3.1337 · Cited by 23
Artificial intelligence and computer-aided diagnosis for colonoscopy: where do we stand now?
Kudo, S.-E., Mori, Y., Abdel-aal, U. M., Misawa, M., Itoh, H., Oda, M., & Mori, K. (2021) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.12.14 · Cited by 21
Barr, M. P., Gray, S. G., Hoffmann, A. C., Hilger, R. A., Thomale, J., O’Flaherty, J. D., Fennell, D. A., Richard, D., O’Leary, J. J., & O’Byrne, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054193 · Cited by 19
Vohra, P., Ngo, H. T., Lee, W. T., & Vo-Dinh, T. (2017) · Analytical Methods · doi:10.1039/c7ay01913k · Cited by 18
Food-Borne Mycotoxicoses: Pathologies and Public Health Impact
Patial, V., Asrani, R. K., & Thakur, M. (2018) · Foodborne Diseases · doi:10.1016/b978-0-12-811444-5.00009-9 · Cited by 18
Chronotherapeutic Drug Delivery
Librodo, P., Buckley, M., Luk, M., & Bisso, A. (2015) · Journal of Infusion Nursing · doi:10.1097/nan.0000000000000140 · Cited by 15
Wang, D., Li, W., Yin, L., Du, Y., Zhang, S., & Suo, J. (2020) · Oncology Letters · doi:10.3892/ol.2020.11350 · Cited by 12
Metadata
- Authors
- Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2005-03-01
- Volume
- 55
- Issue
- 2
- Pages
- 74-108
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2020830322
- Cited by
- 18,196
- References
- 8
- FWCI
- 363.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.